Hemostasis and Blood Clotting Quiz PDF
Document Details
Uploaded by MedPrime
New Mansoura University
Tags
Summary
This document is an exam quiz on hemostasis and blood clotting, containing multiple-choice questions. It covers various aspects of the topic, from basic platelet functions to complex coagulation mechanisms. The quiz is suitable for students in secondary school.
Full Transcript
Hemostasis and Blood Clotting Quiz Part One: Simple MCQs 1. What is the normal platelet count range per mm3 of blood? ○ (A) 50,000 to 100,000 ○ (B) 100,000 to 200,000 ○ (C) 150,000 to 400,000 ○ (D) 400,000 to 500,000 2. Which of the following is NOT a function of platelets? ○ (A) Release...
Hemostasis and Blood Clotting Quiz Part One: Simple MCQs 1. What is the normal platelet count range per mm3 of blood? ○ (A) 50,000 to 100,000 ○ (B) 100,000 to 200,000 ○ (C) 150,000 to 400,000 ○ (D) 400,000 to 500,000 2. Which of the following is NOT a function of platelets? ○ (A) Release of vasoconstricting substances ○ (B) Formation of the primary hemostatic plug ○ (C) Production of red blood cells ○ (D) Release of platelet phospholipids for blood clotting 3. What is the primary role of hemostasis? ○ (A) To increase blood flow ○ (B) To prevent blood clotting ○ (C) To arrest bleeding from injured blood vessels ○ (D) To transport oxygen 4. Which of the following is the first step in hemostasis? ○ (A) Blood clot formation ○ (B) Platelet plug formation ○ (C) Vascular spasm ○ (D) Fibrosis 5. What is the mechanism behind the myogenic response in vascular spasm? ○ (A) Pain reflex causing vasoconstriction ○ (B) Release of chemical substances ○ (C) Direct damage to smooth muscle causing contraction ○ (D) Activation of platelets 6. Which substance inhibits platelet activation and aggregation? ○ (A) Thromboxane A2 ○ (B) Serotonin ○ (C) Aspirin ○ (D) Calcium 7. Which vitamin is essential for the liver's production of several clotting factors? ○ (A) Vitamin A ○ (B) Vitamin B12 ○ (C) Vitamin C ○ (D) Vitamin K 8. What is the role of prothrombin activators in blood clot formation? ○ (A) Convert fibrinogen to fibrin ○ (B) Convert prothrombin to thrombin ○ (C) Activate platelets ○ (D) Inhibit clotting 9. Which of the following is NOT a natural anticoagulant? ○ (A) Heparin ○ (B) Antithrombin III ○ (C) Thrombin ○ (D) Protein C 10. What is the function of plasmin in the fibrinolytic system? ○ (A) Activates plasminogen ○ (B) Digests fibrin threads and other clotting factors ○ (C) Inhibits fibrinolysis ○ (D) Promotes clot formation Part Two: Complex MCQs 11. A patient presents with prolonged bleeding time and normal clotting time. Which of the following conditions is most likely? ○ (A) Hemophilia ○ (B) Purpura ○ (C) Vitamin K deficiency ○ (D) Deep vein thrombosis 12. How does aspirin affect hemostasis? ○ (A) Promotes platelet aggregation ○ (B) Inhibits thromboxane A2 formation, reducing platelet activation ○ (C) Enhances fibrin formation ○ (D) Activates the intrinsic clotting pathway 13. Which of the following statements about clot retraction is FALSE? ○ (A) It involves the contraction of the blood clot. ○ (B) Platelets play a crucial role in clot retraction ○ (C) Serum is formed as a result of clot retraction ○ (D) Clot retraction occurs immediately after clot formation 14. The extrinsic pathway of blood coagulation is initiated by: ○ (A) Contact activation of Factor XII ○ (B) Release of tissue thromboplastin ○ (C) Exposure of blood to collagen ○ (D) Activation of Factor XI 15. Hemophilia A is characterized by a deficiency in which clotting factor? ○ (A) Factor VIII ○ (B) Factor IX ○ (C) Factor X ○ (D) Factor XI 16. Which natural anticoagulant mechanism primarily prevents clot formation on the endothelial surface? ○ (A) Smoothness of the endothelial surface and glycocalyx layer ○ (B) Antithrombin action of fibrin ○ (C) Heparin binding to antithrombin III ○ (D) Rapid blood flow 17. What is the clinical significance of the fibrinolytic system? ○ (A) It promotes the spread of blood clots ○ (B) It helps reopen blocked blood vessels and prevents excessive clotting ○ (C) It initiates the intrinsic clotting pathway ○ (D) It is responsible for the formation of the primary hemostatic plug 18. Which of the following is a potential consequence of endothelial damage? ○ (A) Increased production of prostacyclin ○ (B) Enhanced antithrombin activity ○ (C) Activation of the intrinsic clotting mechanism ○ (D) Prevention of platelet adhesion 19. What is the primary function of thrombodulin in the endothelium? ○ (A) Activates Factor V and VIII ○ (B) Inhibits platelet aggregation ○ (C) Binds with thrombin to inactivate clotting factors ○ (D) Promotes fibrinolysis 20. A patient with liver disease might experience bleeding tendencies due to: ○ (A) Impaired production of clotting factors ○ (B) Increased platelet aggregation ○ (C) Excessive fibrinolysis ○ (D) Enhanced vascular spasm 21. Which of the following best describes disseminated intravascular coagulation (DIC)? ○ (A) Formation of a stable clot at the site of injury ○ (B) Excessive clotting and bleeding due to the consumption of clotting factors ○ (C) Deficiency in a specific clotting factor ○ (D) Inability of platelets to aggregate 22. In the intrinsic pathway of coagulation, which factor is activated first? ○ (A) Factor X ○ (B) Factor IX ○ (C) Factor XII ○ (D) Factor XI 23. What is the role of calcium ions in the coagulation cascade? ○ (A) They are required for all steps of the cascade ○ (B) They are only involved in the extrinsic pathway ○ (C) They are involved in most steps, except for the first two in the intrinsic pathway ○ (D) They inhibit coagulation 24. Which of the following is true regarding the comparison between purpura and hemophilia? ○ (A) Both conditions result in prolonged clotting time ○ (B) Purpura is characterized by a deficiency in clotting factors, while hemophilia is caused by low platelet count ○ (C) Hemophilia is a congenital disorder, while purpura can be acquired ○ (D) Both conditions are equally common in males and females 25. The process of fibrinolysis is primarily mediated by: ○ (A) Thrombin ○ (B) Plasmin ○ (C) Factor XIII ○ (D) Tissue plasminogen activator (t-PA) inhibitor Answer Guide 1. C 2. C 3. C 4. C 5. C 6. C 7. D 8. B 9. C 10. B 11. B 12. B 13. D 14. B 15. A 16. A 17. B 18. C 19. C 20. A 21. B 22. C 23. C 24. C 25. B Done